Trial Profile
Study to evaluate the association between Apolipoprotein E polymorphism and intravitreal Ranibizumab treatment response in patients with Wet Age-Related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 28 Aug 2017 New trial record